NIH-NINDS - 22-003193 - Notice of Intent

Submitted by patelsnv on
Post Date/ Solicitation Issue Date
Closing Response Date
Proposed Award Date
Project Title
DMi8 Fluorescent Microscope
Contracting Office
National Institute of Neurological Disorders and Stroke (NINDS)

Contact Points

Primary Contract Specialist

Valerie
Gregorio
valerie.gregorio@nih.gov
NAICS Code Number
334516
Analytical Laboratory Instrument Manufacturing
Small Business Size Standard
1,000 employees
FPDS Classification Code
N/A
Estimated Period of Performance
N/A
Delivery of Goods
BLDG 10 RM 3D17
Set-Aside Status
Not Set Aside
Competition Status
Brand Name Only
Vendor Name
Leica Microsystems, Inc.
Address
1700 Leider Lane
Buffalo Grove, IL 60090
United States
Single-Sole Source Determination
The investigators have been making use of multiplex immunofluorescent chemistry for characterization of interrogation of the dynamic role of primary cilia in human GBM tumorigenesis and treatment resistance. Fluorescence microscopy is a critical tool for probing biological systems. DMi8 provides widefield fluorescence microscopy in addition to brightfield, darkfield, phase contrast, differential interference, contrast, and modulation contrast imaging. It simultaneously images a wide range of fluorophores with a workflow involving the high-end Stellaris confocal microscope are essential. A complete list of the unique features of the system are attached. Access to the DMi8 will allow the investigators to probe various biological systems in a manner that allows subsequent use of the acquired data to improve efficiency with acquisition of higher resolution images on the Stellaris confocal microscope. For these purposes, this fluorescent microscope will meet the criteria as following.
1. Widefield to Confocal workflow
We have been approved for acquisition of the Leica Stellaris 8 Confocal Microscope which itself provides several technical advantages not matched by other current systems.
a. The DMi8 with the LAS X Navigator software allows widefield data to be loaded onto the
STELLARIS and aligned to the same physical sample (e.g., 1x3-inch slide) for more
demanding confocal imaging of that same sample.
b. This advantage frees up valuable instrument time on the STELLARIS as preview tile
scans need not be collected on the confocal
c. This improves the economics of system utilization allowing more access for additional users.
d. There are no other manufacturers of Stellaris-compatible widefield microscopes.

2. Hardware compatibility with existing Leica instruments and components.
Hardware components such as objectives, stage inserts, and cameras can be shared
between the DMi8 widefield system and the Stellaris confocal system allowing for
additional cost savings and efficiencies. Other manufacturers do not share hardware compatibility.

3. LAS X Software provides a consistent software and user interface across Leica instruments.


Acquisition of a widefield system that uses the same software as the Stellaris confocal offers a unique workflow advantage (see #1) but also provides consistency between system and obviate need to learn a different system. This will decrease training time and allow for faster attainment of competence on both systems. Other manufacturers do not share software compatibility with the Stellaris system.

The Leica DMi8 fluorescence microscope is the only instrument that meets our current needs (please refer to sole source justification documentation) given the requirement for hardware and software compatibility with the Leica Stellaris confocal microscope. Nonetheless, we did contact knowledgeable investigators within NINDS. The consensus is that given the uniqe advantages of the DMi8 which cannot be replicated by other manufacturers, consideration of other systems would not be advised. Nonetheless, we reviewed product information regarding the Zeiss Axio Observer, the Olympus IXplore Live Cell Imaging Microscope System, and the EVOS Cell Imaging System. In addition to the innate advantages of the compatibility of the Leica DMi8 system, we also found several advantages regarding optical features, range of fluorophores, speed of acquisition.

As a conclusion, DMi8 by Leica is the only instrument fulfill these needs.

Background/Description of Requirement

The NINDS is a part of the National Institutes of Health (NIH), conducting research into the causes, treatment, and prevention of neurological disorders and stroke. The NINDS mission is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. The SNB studies primary brain tumors, pituitary tumors, syringomyelia, drug delivery to the central nervous system, development of surgical technology/techniques, cell death in neurologic disorders and functional neurosurgery. SNB provides diagnostic services for the Clinical Center to support and evaluate on-going medical care and research activities.  DMi8 fluorescent microscope will be used in the following works.

      -   Assessment of the blood-brain barrier in adult and pediatric CNS malignancies.

      -  Interrogation of the dynamic role of primary cilia in GBM tumorigenesis and treatment resistance.

      -  Evaluation of the molecular and cell biological underpinnings of epilepsy.

     -   Investigation of subcellular regulation of tumorigenesis in pituitary adenomas.

Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.

All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.